CD8A and allergic disease: Indeed, mTOR inhibition attenuated OVA-mRNA-LNP–induced CD8+ T cells in the lung and the CD38+KLRG1– CD8+ T cell subset, including perforin production (Figure 4B), while preserving the anti-allergy effect of the vaccination.